Despite higher METTL3 expression being significantly associated with lower tumour grade, ER and PR positivity, and non-TNBC status, METTL3 expression did not correlate with survival outcomes in our patient cohort, when considering the cohort as a whole. The gene discussed is PGR; the disease is neoplasm.